Baymark Partners Acquires New Promise Neuropathy

Baymark Partners acquired New Promise Neuropathy on an undisclosed date. This was Baymark Partners's 20th publicly tracked acquisition out of 26 we have on record.

The price Baymark Partners paid for New Promise Neuropathy was not publicly disclosed. Only 0 of Baymark Partners's 26 tracked acquisitions have a disclosed price.

Baymark Partners acquired New Promise Neuropathy, a lower middle market healthcare business.

Baymark Partners has made 3 acquisitions in Healthcare, including New Promise Neuropathy. See the full list on the Healthcare and Baymark Partners acquisition pages.